TP53 and ovarian cancer: A sulforhodamine-B (SRB) assay was used to investigate growth inhibition by Nutlin-3/RG7388 or rucaparib for a panel of wild-type and mutant TP53 ovarian cancer cell lines derived from tumors of different histological subtypes [19–22] (Figure 1 and Table 1).